Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Reinvestment Rate
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Reinvestment Rate of 1.04x as of June 2023, reinvesting €147.33 Million (capex €53.01 Million plus investments €-94.32 Million) from operating cash flow of €141.99 Million. Check how high is Shanghai Haohai Biological Technology Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Shanghai Haohai Biological Technology Co. Ltd across 9 annual periods. Explore debt repayment capacity of Shanghai Haohai Biological Technology Co to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Shanghai Haohai Biological Technology Co. Ltd. For live market cap and broader valuation context, see 5HB stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.47x | €951.62 Million | €648.57 Million | €365.49 Million | ▼ -0.4% |
| 2023 | 1.47x | €934.29 Million | €634.45 Million | €343.10 Million | ▼ -56.2% |
| 2022 | 3.36x | €777.76 Million | €231.30 Million | €309.21 Million | ▲ +255.7% |
| 2021 | 0.95x | €323.55 Million | €342.29 Million | €270.88 Million | ▼ -52.3% |
| 2020 | 1.98x | €519.25 Million | €262.07 Million | €189.70 Million | ▼ -26.2% |
| 2019 | 2.68x | €936.19 Million | €348.91 Million | €249.18 Million | ▲ +37.7% |
| 2018 | 1.95x | €762.61 Million | €391.28 Million | €151.21 Million | ▲ +53.2% |
| 2017 | 1.27x | €436.50 Million | €343.06 Million | €134.29 Million | ▼ -79.6% |
| 2016 | 6.24x | €1.59 Billion | €254.49 Million | €75.67 Million | — |